TD Cowen lowered the firm’s price target on Teladoc to $15 from $16 and keeps a Hold rating on the shares. The firm said revenues and adjusted EBITDA beat consensus and 2024 guide was reiterated, though there remain questions on how the company can reinvigorate growth particularly in BetterHelp.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TDOC:
- Options Volatility and Implied Earnings Moves Today, April 25, 2024
- Optum virtual care exit ‘clear positive’ for Teladoc, says BofA
- UnitedHealth’s Optum closing virtual care business, Endpoints says
- Options Volatility and Implied Earnings Moves This Week, April 22 – April 26, 2024
- Teladoc Health Provides Updated Start Time for First Quarter 2024 Earnings Call on April 25
